These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

239 related items for PubMed ID: 23102196

  • 1. [Analysis of prognostic factors in osteosarcoma adult patients, a single institution experience].
    Adamkova Krakorova D, Vesely K, Zambo I, Tucek S, Tomasek J, Jureckova A, Janicek P, Cerny J, Pazourek L, Ondrusek S, Selingerova I.
    Klin Onkol; 2012; 25(5):346-58. PubMed ID: 23102196
    [Abstract] [Full Text] [Related]

  • 2. Metastatic osteosarcoma at diagnosis: prognostic factors and long-term outcome--the French pediatric experience.
    Mialou V, Philip T, Kalifa C, Perol D, Gentet JC, Marec-Berard P, Pacquement H, Chastagner P, Defaschelles AS, Hartmann O.
    Cancer; 2005 Sep 01; 104(5):1100-9. PubMed ID: 16015627
    [Abstract] [Full Text] [Related]

  • 3. [Multivariate analysis for prognostic factors among 43 patients with osteosarcoma].
    Zhang B, Pang QJ, Zhang HJ, Yuan Y.
    Zhongguo Gu Shang; 2011 Dec 01; 24(12):982-6. PubMed ID: 22276503
    [Abstract] [Full Text] [Related]

  • 4. Primary metastatic osteosarcoma: presentation and outcome of patients treated on neoadjuvant Cooperative Osteosarcoma Study Group protocols.
    Kager L, Zoubek A, Pötschger U, Kastner U, Flege S, Kempf-Bielack B, Branscheid D, Kotz R, Salzer-Kuntschik M, Winkelmann W, Jundt G, Kabisch H, Reichardt P, Jürgens H, Gadner H, Bielack SS, Cooperative German-Austrian-Swiss Osteosarcoma Study Group.
    J Clin Oncol; 2003 May 15; 21(10):2011-8. PubMed ID: 12743156
    [Abstract] [Full Text] [Related]

  • 5. Prognostic factors for osteosarcoma of the extremity treated with neoadjuvant chemotherapy: 15-year experience in 789 patients treated at a single institution.
    Bacci G, Longhi A, Versari M, Mercuri M, Briccoli A, Picci P.
    Cancer; 2006 Mar 01; 106(5):1154-61. PubMed ID: 16421923
    [Abstract] [Full Text] [Related]

  • 6. Osteosarcoma in patients older than 65 years.
    Longhi A, Errani C, Gonzales-Arabio D, Ferrari C, Mercuri M.
    J Clin Oncol; 2008 Nov 20; 26(33):5368-73. PubMed ID: 18809616
    [Abstract] [Full Text] [Related]

  • 7. Influence of local recurrence on survival in patients with extremity osteosarcoma treated with neoadjuvant chemotherapy: the experience of a single institution with 44 patients.
    Bacci G, Longhi A, Cesari M, Versari M, Bertoni F.
    Cancer; 2006 Jun 15; 106(12):2701-6. PubMed ID: 16691623
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. [Poor prognosis of osteosarcoma of pelvis; 39 years of registration by the Netherlands Commission on Bone Tumors].
    Ham SJ, Kroon HM, Schraffordt Koops H, Hoekstra HJ.
    Ned Tijdschr Geneeskd; 2000 Jan 15; 144(3):121-5. PubMed ID: 10674118
    [Abstract] [Full Text] [Related]

  • 10. The impact of age on long-term outcome in patients with endometrial cancer treated with postoperative radiation.
    Jolly S, Vargas CE, Kumar T, Weiner SA, Brabbins DS, Chen PY, Floyd W, Martinez AA.
    Gynecol Oncol; 2006 Oct 15; 103(1):87-93. PubMed ID: 16545441
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Primary osteogenic sarcoma with pulmonary metastasis: clinical results and prognostic factors in 91 patients.
    Wu PK, Chen WM, Chen CF, Lee OK, Haung CK, Chen TH.
    Jpn J Clin Oncol; 2009 Aug 15; 39(8):514-22. PubMed ID: 19525290
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Pattern of disease recurrence and prognostic factors in patients with osteosarcoma treated with contemporary chemotherapy.
    Hawkins DS, Arndt CA.
    Cancer; 2003 Dec 01; 98(11):2447-56. PubMed ID: 14635080
    [Abstract] [Full Text] [Related]

  • 15. Long-term results (>25 years) of a randomized, prospective clinical trial evaluating chemotherapy in patients with high-grade, operable osteosarcoma.
    Bernthal NM, Federman N, Eilber FR, Nelson SD, Eckardt JJ, Eilber FC, Tap WD.
    Cancer; 2012 Dec 01; 118(23):5888-93. PubMed ID: 22648705
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Osteosarcoma of the head and neck region: lessons learned from a single-institution experience of 50 patients.
    Laskar S, Basu A, Muckaden MA, D'Cruz A, Pai S, Jambhekar N, Tike P, Shrivastava SK.
    Head Neck; 2008 Aug 01; 30(8):1020-6. PubMed ID: 18383528
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Post operative infection and increased survival in osteosarcoma patients: are they associated?
    Jeys LM, Grimer RJ, Carter SR, Tillman RM, Abudu A.
    Ann Surg Oncol; 2007 Oct 01; 14(10):2887-95. PubMed ID: 17653803
    [Abstract] [Full Text] [Related]

  • 20. Adjuvant and neoadjuvant chemotherapy for osteosarcoma of the extremities: 27 year experience at Rizzoli Institute, Italy.
    Bacci G, Longhi A, Fagioli F, Briccoli A, Versari M, Picci P.
    Eur J Cancer; 2005 Dec 01; 41(18):2836-45. PubMed ID: 16298125
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.